Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

By E. Masci, G. Toti, A. Mariani, S. Curioni, A. Lomazzi, M. Dinelli, G. Minoli, C. Crosta, U. Comin, A. M. Fertitta and 3 more. American Journal of Gastroenterology, 2001

1,050 citations recorded by the source corpus.

Subfields: Microbiology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/55c172b49e925cb4d005734bdb4e6797ab143263

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. M. Freeman
2. Suryakanth R. Gurudu

Citations in the corpus

• Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014 (2014, methodology): “U nau t ho r i z ed d i s t r i bu t i on i s s t r i c t l y p r oh i b i t ed . tive, multicenter studies that analyzed potential risk factors for PEP using multivariate analysis [6,16,17,21,22].”
• Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies (2007, background): “The international consensus definition of postprocedural complications and their grading for severity was followed by the majority of studies, whereas inhouse criteria were presented in six reports (8, 12, 17, 19, 20, 26) or missing in four (13, 14, 18, 25).”
• Adverse events associated with ERCP. (2017, background): “6%.(10,66,113) Perforations must be promptly diagnosed and treated, because delayed therapy may result in sepsis and multiple organ failure, which are associated with an 8% to 23% mortality rate.”
• Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study (2006, background): “However, precutting was associated with a higher risk of pancreatitis in two other multicenter studies involving endoscopists with varied experience in ERCP (11, 16), and in the meta-analysis study (23).”